据《ArthritisRheum》2006年第5期的报道,英国研究人员对具有手和腕损害的早期类风湿关节炎患者予唑来膦酸(唑来膦酸组)或安慰剂(安慰剂组)治疗。26周时唑来膦酸组的磁共振检查结果示手和腕关节损害的平均个数较安慰剂组下降61%,且唑来膦酸组出现新的骨肿胀患者的比例少于安慰 According to ArthritisRheum, Issue 5, 2006, British researchers treated zolephos (zoledronic acid) or placebo (placebo) patients with early-stage rheumatoid arthritis with hand and wrist lesions. At week 26, magnetic resonance imaging of the zoledronic acid group showed that the average number of hand and wrist injuries was 61% lower than placebo, and the proportion of patients with new bone swelling in the zoledronic acid group was less than that of comfort